Logo image
Keeping Up With Technological Innovation: The Moral Imperative for Pragmatic Clinical Trials in Interventional Pulmonology
Journal article   Peer reviewed

Keeping Up With Technological Innovation: The Moral Imperative for Pragmatic Clinical Trials in Interventional Pulmonology

Fabien Maldonado, Rafael Paez, Robert J. Lentz, Ankush Ratwani and Jonathan D. Casey
Chest, Vol.167(3)
2025

Abstract

Bronchoscopy Comparative Effectiveness Research Humans Inventions Lung Neoplasms Pragmatic Clinical Trials as Topic Pulmonary Medicine clinical article clinician comparative effectiveness diagnostic value disruptive technology human morality patient care physician pragmatic trial pulmonologist pulmonology randomized controlled trial Review treatment outcome invention lung tumor procedures randomized controlled trial (topic) therapy Lung Cancer Ethics
The advances in minimally invasive lung cancer diagnostics of the last decade have transformed patient care but have also raised important concerns about the regulatory processes used to approve new devices and the best way to generate data to support their use. Disruptive technologies, such as robotic bronchoscopy, have been widely adopted by interventional pulmonologists in the absence of robust data demonstrating improved patient outcomes. Comparative research is needed to inform patient care, but traditional methods of conducting clinical trials in which research teams operate separately from clinical teams are ill-suited to testing the safety and effectiveness of technologies being introduced on the market at unprecedented speed. Pragmatic clinical trials, which integrate trial procedures into routine clinical care, represent an appealing alternative approach for generating much-needed data to inform clinical care. In this article we illustrate the advantages and disadvantages of these research paradigms, using two recently completed randomized controlled trials in navigational bronchoscopy, and highlight the barriers and facilitators to using pragmatic trials to address the gap in comparative effectiveness research: these include the need for increased clarity of research regulations for pragmatic trials, adequate federal and private funding for such research, and alignment of incentives between clinicians, researchers, regulators, and industry. © 2024 American College of Chest Physicians

Metrics

8 Record Views

Details

Logo image